LD, D., M, M., RS, D., AP, Q., B, M., KR, C., . . . MD, F. (2022). Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study. Current medical research and opinion, 38(8), 1267. https://doi.org/10.1080/03007995.2022.2033560
Chicago Style (17th ed.) CitationLD, Dillon, et al. "Expanded Evidence That the 31-gene Expression Profile Test Provides Clinical Utility for Melanoma Management in a Multicenter Study." Current Medical Research and Opinion 38, no. 8 (2022): 1267. https://doi.org/10.1080/03007995.2022.2033560.
MLA (9th ed.) CitationLD, Dillon, et al. "Expanded Evidence That the 31-gene Expression Profile Test Provides Clinical Utility for Melanoma Management in a Multicenter Study." Current Medical Research and Opinion, vol. 38, no. 8, 2022, p. 1267, https://doi.org/10.1080/03007995.2022.2033560.